After Maggi, Patanjali Atta Noodles found ‘sub-standard’

  • News
  • April 15, 2016

Meerut

A team of Food Safety and Drugs Administration (FSDA) based in Meerut has found a Patanjali Atta Noodles sample “sub-standard”, with ash content in the taste maker exceeding the prescribed limits by nearly three times, even higher than Maggi samples. The tests were carried out on samples of Patanjali Noodles, Maggi and Yippee collected from Meerut on February 5, 2016, the report of which reached came out on Saturday. In all the three samples, ash content found is invariably high.The permissible limit for ash content according to law is 1%, but all the three samples failed the test and were found “substandard” for consumption.

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • News
    • May 27, 2025
    • 282 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

    Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

    Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates